Latest Videos

Latest News

Industry Outlook 2025: Looking at the Investment Environment

Industry Outlook 2025: Looking at the Investment Environment

March 6th 2025

In an interview with Pharmaceutical Technology®, Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the M&A landscape from 2024 and his expectations of what is to come next.

Industry Outlook 2025: Experts Weigh in on the Most Impactful Trends for Industry

Industry Outlook 2025: Experts Weigh in on the Most Impactful Trends for Industry

February 10th 2025

Experts provide their insights into the trends that have shaped the global bio/pharma industry in 2024 and give their predictions as to what may be impactful in 2025 and beyond.

Industry Outlook 2025: The Rising Prominence of AI in Pharma

Industry Outlook 2025: The Rising Prominence of AI in Pharma

February 7th 2025

In this interview, Pharmaceutical Technology® discusses the trend of AI in pharma and how it may play out in 2025 and beyond with Ben Sidders from Biorelate.

Trenchant BioSystems Partners with Autolomous to Form Integrated Automated CGT Manufacturing Platform

Trenchant BioSystems Partners with Autolomous to Form Integrated Automated CGT Manufacturing Platform

January 24th 2025

The collaboration will combine fully automated and digitalized technologies to reduce CGT manufacturing timelines to 2.5 days.

Cytiva Collaborates with Cellular Origins to Deliver Automated Manufacturing for CGTs

Cytiva Collaborates with Cellular Origins to Deliver Automated Manufacturing for CGTs

January 22nd 2025

Cytiva will combine its CGT manufacturing technologies with Cellular Origins' robotic manufacturing platform.

Samsung Biologics Scores Major Manufacturing Deal Worth Over $1.4 Billion with European Pharma Company

Samsung Biologics Scores Major Manufacturing Deal Worth Over $1.4 Billion with European Pharma Company

January 17th 2025

Production is set to take place at Samsung Biologics’ Songdo, South Korea, site, and the agreement will run through December 2030, subject to change.

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

January 15th 2025

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.

Behind the Headlines: 2024 Year in Review

Behind the Headlines: 2024 Year in Review

January 8th 2025

Vanessa Almendro, Elliot Berger, Benjamin McCloud, and Turna Ray go behind the headlines to discuss 2024’s biggest trends in the pharmaceutical industry, as well as the unforeseen outcomes that took us by surprise.

Roche Forms Partnership Worth Potentially More than $1 Billion with Innovent to Develop Novel ADC for SCLC

Roche Forms Partnership Worth Potentially More than $1 Billion with Innovent to Develop Novel ADC for SCLC

January 3rd 2025

Under the agreement, the companies will advance development of IBI3009, Innovent’s ADC candidate, which has received IND approvals in the US, China, and Australia.

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Orexo and Abera Partner to Develop Nasal Powder Vaccines

December 20th 2024

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.